Covestor LTD Castle Biosciences Inc Transaction History

Covestor LTD

$160 Million
Q4 2024

A detailed history of Covestor LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Covestor LTD holds 936 shares of CSTL stock, worth $24,476. This represents 0.02% of its overall portfolio holdings.

Number of Shares

936

Holding current value

$24,476

% of portfolio

0.02%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$26.52 - $34.67 $24,822 - $32,451	936 New	936 $25,000
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $232 - $328	-7 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$39.06 - $67.58 $273 - $473	7 New	7 $0

Others Institutions Holding CSTL

# of Institutions

210

Shares Held

26.6M

Call Options Held

128K

Put Options Held

35.4K

Black Rock Inc. New York, NY

3.04M
Shares

$79.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.83M
Shares

$47.9 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

1.8M
Shares

$47 Million
0.24% of portfolio
Principal Financial Group Inc Des Moines, IA

1.44M
Shares

$37.5 Million
0.02% of portfolio
Dimensional Fund Advisors LP Austin, TX

999K
Shares

$26.1 Million
0.01% of portfolio

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $688M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account